Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

BRAF phosphorylates MAP2K1 on serine. 2 / 2

| 1 1

➶

reach

"BRAF phosphorylates regulatory serine residues on MEK1 and MEK2 and mutation of BRAF results in activation of the RAS/RAF/MEK/ERK pathway, leading to cellular proliferation and a series of anti-apoptotic and potentially immunoregulatory events that culminate in the progression of this tumor."

22876817

➶

sparser

"BRAF phosphorylates regulatory serine residues on MEK1 and MEK2 and mutation of BRAF results in activation of the RAS/RAF/MEK/ERK pathway, leading to cellular proliferation and a series of anti-apoptotic and potentially immunoregulatory events that culminate in the progression of this tumor."

22876817

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...